FILE:CVS/CVS-8K-20051006153402.txt.gz
EVENTS:	Results of Operations and Financial Condition	Financial Statements and Exhibits
TEXT:
ITEM: Results of Operations and Financial Condition
ITEM: Financial Statements and Exhibits
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
 
 
 
Item 2.02 Results of Operations and Financial Condition.
 
On October 6, 2005, CVS Corporation issued a press release announcing its sales results for the period ended October 1, 2005. In addition, the Corporation narrowed its diluted earnings per share guidance for the third quarter ending October 1, 2005. Attached to this Current Report on Form 8-K as Exhibit 99.1, is a copy of the Corporation's related press release dated October 6, 2005.
 
The information in this report is being furnished, not filed. Accordingly, the information in Item 9.01 of this report will not be incorporated by reference into any registration statement filed by the Corporation under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference.
 
Item 9.01 Financial Statements and Exhibits.
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

Exhibit 99.1
 
 
 
 
WOONSOCKET, RHODE ISLAND, October 6, 2005  CVS Corporation (NYSE: CVS) today announced that total sales for the five-week period ended October 1, 2005 increased 7.3% to $3.5 billion, compared to $3.3 billion in the prior year period. Total pharmacy sales represented 71.1% of total company sales in September.
 
Same store sales (sales from stores open more than one year) for the five weeks ended October 1, 2005 increased 5.7% over the prior year period. Pharmacy same store sales increased 5.6%, despite being negatively impacted by approximately 170 basis points due to recent generic introductions, which are being substituted for higher priced brand named drugs. Front-end same store sales increased 5.9%. Same store sales exclude stores closed for seven or more consecutive days as a result of hurricanes Katrina and Rita.
 
Beginning with the four weeks ended August 27, 2005, same store sales include the impact of the acquisition completed on July 31, 2004, of 1,268 drugstores. The inclusion of the acquired stores benefited total September same store sales by approximately 150 basis points, as both front-end and pharmacy same store sales at the acquired stores positively impacted the overall results.
 
For the third quarter, total sales increased 13.4% to $9.0 billion, compared to $7.9 billion in the prior year period. Same store sales for the thirteen weeks ended October 1, 2005 increased 5.7% over the prior year period. Pharmacy same store sales increased 5.8%, while front-end same store sales increased 5.4%. Total pharmacy sales represented 70.6% of total company sales in the quarter.
 
The Company is narrowing its earnings guidance for the third quarter from a range of $0.29 to $0.31 cents per diluted share to a range of $0.29 to $0.30 cents per diluted share. The Company will announce its third quarter earnings results on November 3, 2005.
 
Year-to-date, total sales for the thirty-nine week period ended October 1, 2005, increased 25.9% to $27.3 billion, compared to $21.7 billion in 2004. Same store sales for the thirty-nine week period increased 6.5% over the prior year period. Pharmacy same store sales increased 7.3%, while front-end same store sales increased 4.6%.
 
CVS is America's largest retail pharmacy, operating 5,461 retail and specialty pharmacy stores (including stores which remain closed as a result of hurricanes Katrina and Rita) in 37 states and the District of Columbia as of October 1, 2005. With more than 40 years of dynamic growth in the retail pharmacy industry, CVS is committed to being the easiest pharmacy retailer for customers to use. CVS has created innovative approaches to serve the healthcare needs of all customers through its CVS/pharmacy stores; its online pharmacy, CVS.com; and its pharmacy benefit management, mail order and specialty pharmacy subsidiary, PharmaCare. General information about CVS is available through the Investor Relations portion of the Company's website, at , as well as through the pressroom portion of the Company's website, at .
http://investor.CVS.com
www.cvs.com/pressroom
This press release contains certain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially. For these statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company strongly recommends that you become familiar with the specific risks and uncertainties outlined under the caption "Cautionary Statement Concerning Forward-Looking Statements" in its Quarterly Report on Form 10-Q for the period ended July 2, 2005.
 


